Abivax (ABVX) Enterprise Value (2021 - 2025)
Abivax (ABVX) has 2 years of Enterprise Value data on record, last reported at -$27.5 million in Q4 2022.
- For Q4 2022, Enterprise Value rose 60.4% year-over-year to -$27.5 million; the TTM value through Dec 2022 reached -$27.5 million, up 60.4%, while the annual FY2023 figure was -$272.5 million, 859.47% down from the prior year.
- Enterprise Value reached -$27.5 million in Q4 2022 per ABVX's latest filing, up from -$69.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$27.5 million in Q4 2022 and bottomed at -$69.4 million in Q4 2021.